COHANCE LIFESCIENCES LTD Intrinsic Value
COHANCE · Healthcare · Current price ₹460.85
Is COHANCE LIFESCIENCES LTD undervalued?
DocStoX estimates the fair value of COHANCE LIFESCIENCES LTD at ₹182 per share, versus the current market price of ₹461. That puts the stock about -60.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹77), Relative P/E (₹183), Graham floor (₹104), Analyst target (₹509). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹77 (bear) to ₹182 (base) to ₹509 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹461 versus an intrinsic value of ₹182, COHANCE LIFESCIENCES LTD currently offers -60.4% of negative margin (i.e. a premium).
More on COHANCE LIFESCIENCES LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.